IP Library Granted Patent US 10,940,300
Granted Patent B2
US 10,940,300 · App. 15/888,330 · Granted Mar 9, 2021

Medicament applicator

Inventors: Jamelo J. Mellejor (Bridgewater, NJ); Sanjeev K. Gupta (Bridgewater, NJ); Dipen Desai (Whippany, NJ)
Assignee: Kashiv Pharma, LLC
A61M31/007A61M3/0262A61M5/178A61M5/315A61M5/31501A61M37/0069A61M2005/005A61M2210/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,940,300
App. No.
15/888,330
Granted
Mar 9, 2021
Kind
B2
Abstract

Apparatus and methods for inserting a medicament into a body cavity are described. The apparatus comprises an elongate tube with a plunger rod therein. The plunger rod has at least one projection which cooperatively interacts or engages with at least one discontinuity on the inside of the elongate tube so that proximal movement of the plunger rod with respect to the elongate tube expels the medicament into the body cavity.

Claims (30)

1. An assembly for introducing a medicament into a body cavity, the assembly comprising:

an elongate tube having a proximal end, a distal end, an outer surface, an inner surface and an opening extending from the distal end to the proximal end, the proximal end adapted to support a medicament, the elongate tube comprising at least one radial discontinuity adjacent the distal end and extending inwardly from the inner surface of the tube; and

a plunger rod having an elongate body with a distal end and a proximal end, the plunger rod adapted to be slidably engaged within the tube, the plunger rod comprising at least two axially spaced projections adjacent the distal end of the elongate body that cooperatively engages with the at least one radial discontinuity.

2. The assembly of claim 1 , wherein the at least one radial discontinuity on the elongate tube cooperatively engages between the at least two axially spaced projections on the elongate body of the plunger rod.

3. The assembly of claim 2 , wherein when the at least one radial discontinuity on the elongate tube is cooperatively engaged between the at least two axially spaced projections on the elongate body of the plunger rod, spontaneous movement of the plunger rod distally or proximally with respect to the elongate tube is substantially prevented.

4. The assembly of claim 1 , wherein the proximal end of the elongate tube contains a medicament.

5. The assembly of claim 4 , wherein the medicament is a tablet.

6. The assembly of claim 5 , wherein the tablet comprises an estrogen compound.

7. The assembly of claim 5 , wherein the tablet comprises from about 10 mcg to about 25 mcg of an estrogen compound.

8. The assembly of claim 4 , wherein the at least two axially spaced projections on the elongate body are positioned a sufficient distance from the distal end of the plunger rod such that when the at least one radial discontinuity on the elongate tube is cooperatively engaged between the at least two axially spaced projections, proximal movement of the plunger rod with respect to the elongate tube causes the proximal end of the plunger rod to expel the medicament from the proximal end of the elongate tube.

9. A method of depositing a medicament into a body cavity, the method comprising:

inserting the distal end of the elongate tube of the assembly of claim 8 into the body cavity; and

expelling the medicament into the body cavity.

10. The method of claim 9 wherein the step of expelling the medicament comprises applying proximally directed pressure to the proximal end of the plunger rod such that the plunger rod moves proximally with respect to the elongate tube causing the at least one radial discontinuity on the elongate tube to disengage from the at least two radial projections on the elongate body of the plunger rod.

11. The method of claim 9 , wherein the medicament is a tablet.

12. The method of claim 11 , wherein the tablet comprises an estrogen compound.

13. The method of claim 11 , wherein the tablet comprises from about 10 mcg to about 25 mcg of an estrogen compound.

14. The method of claim 13 , wherein the body cavity is a vagina.

15. The assembly of claim 1 , wherein the elongate body of the plunger rod comprises two intersecting beams extending from the distal end to the proximal end, such that elongate body has a cruciform-shaped cross section comprising four rays.

16. The assembly of claim 15 , wherein two of the four rays each contain two axially spaced projections.

17. The assembly of claim 1 , wherein the distal end of the plunger rod is undivided.

18. The assembly of claim 1 , wherein the distal end of the plunger rod is blunt or rounded.

19. The assembly of claim 1 , wherein the proximal end of the elongate tube comprises at least two tongues adapted to support the medicament.

20. The assembly of claim 19 , wherein the at least two tongues each comprise recessed walls adapted to engage the surface of the medicament.

21. The assembly of claim 19 , wherein the at least two tongues prevent the medicament from being prematurely expelled from the proximal end of the elongate tube.

22. The assembly of claim 19 , wherein the proximal end of the elongate tube further comprises at least two lips adapted to prevent lateral movement of the medicament.

23. The assembly of claim 22 , wherein the at least lips are biased inward from the outer surface of the elongate tube at its proximal end.

24. The assembly of claim 1 , wherein the plunger rod further comprises a thumbpress on the distal end.

25. The assembly of claim 1 , wherein the outer surface of the elongate tube comprises at least one roughened surface adapted to prevent slippage of the elongate tube between a user's fingers.

26. The assembly of claim 1 , wherein each of the elongate tube and plunger rod are made from a material comprising one or more of polypropylene and high-density polyethylene.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2021
From: KASHIV BIOSCIENCES, LLC
To: KASHIV SPECIALTY PHARMACEUTICALS, LLC
Reel/Frame 057565/0707 →
CHANGE OF NAME Recorded Sep 22, 2021
From: KASHIV SPECIALTY PHARMACEUTICALS, LLC
To: AMNEAL COMPLEX PRODUCTS RESEARCH LLC
Reel/Frame 057570/0078 →
CHANGE OF NAME Recorded Sep 20, 2021
From: KASHIV PHARMA, LLC
To: KASHIV BIOSCIENCES, LLC
Reel/Frame 057540/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2018
From: MELLEJOR, JAMELO J.; GUPTA, SANJEEV K.; DESAI, DIPEN
To: KASHIV PHARMA, LLC
Reel/Frame 044839/0230 →
Continuity (3)
Continuation 15344803 · Nov 7, 2016
Continuation 13921429 · Jun 19, 2013
Related Publication 20180154125A1 · Jun 7, 2018